Tirzepatide 20mg / 40mg

Tirzepatide is a medication that acts on both GIP and GLP-1 receptors to help regulate blood sugar and appetite.

What you get in the box : Ready to use with Kwikpen, 4x sterile points and disinfection swabs for weekly controlled dosage injections over 4 weeks.

Uses of tirzepatide

1. Type 2 diabetes

Tirzepatide is approved to improve blood sugar control in adults with Type 2 Diabetes. It can significantly lower HbA1c levels and often leads to weight loss as an additional benefit.

2. Obesity and overweight

Tirzepatide is also approved for chronic weight management in adults with obesity, or those who are overweight and have weight-related health conditions. It works by reducing appetite, increasing feelings of fullness, and slowing stomach emptying.

Common side effects

The most common side effects are digestive and are usually more noticeable when starting treatment or increasing the dose. They often improve over time.

• ➡️ Nausea
• ➡️ Diarrhea
• ➡️ Constipation
• ➡️ Vomiting
• ➡️ Stomach pain
• ➡️ Indigestion (dyspepsia)
• ➡️ Reduced appetite
• ➡️ Fatigue
• ➡️ Injection-site reactions
• ➡️ Hair loss (reported in some weight-loss studies)

Serious but less common side effects

Seek medical attention if you develop symptoms such as:

• 👉 Severe, persistent abdominal pain, which may indicate Acute Pancreatitis
• 👉 Symptoms of gallbladder disease (severe upper abdominal pain, fever, jaundice)
• 👉 Severe allergic reactions (swelling of the face or throat, difficulty breathing)
• 👉 Signs of dehydration or kidney problems due to prolonged vomiting or diarrhea
• 👉 Low blood sugar, especially if used with insulin or certain other diabetes medications
• 👉 Significant vision changes in people with diabetic eye disease

Important warnings

• 🔴 Tirzepatide carries a warning about thyroid C-cell tumors based on animal studies. It should generally not be used by people with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia type 2 (MEN2).
• 🔴 A small risk of pancreatitis has been reported with GLP-1–related medications, including tirzepatide.
• 🔴 Gastrointestinal side effects are the most common reason people discontinue treatment.

Tips to reduce side effects

• * Eat smaller meals.
• * Avoid very fatty or greasy foods.
• * Stay well hydrated.
• * Increase doses only as prescribed.
• * Contact your clinician if vomiting, severe abdominal pain, or inability to keep fluids down occurs.

If you're considering tirzepatide for diabetes or weight loss, I can also explain its effectiveness, expected weight loss, dosing schedule, and how it compares with Semaglutide.

Tirzepatide should be stored according to the manufacturer's instructions:

• -Refrigerated storage (preferred)
• -Keep in a refrigerator at 2°C to 8°C (36°F to 46°F).
• -Store in the original carton to protect it from light.
• -Do not freeze. If the pen has been frozen, do not use it.

Room temperature storage

• -Tirzepatide pens can generally be kept at room temperature up to 30°C (86°F) for up to 21 days.
• -Once kept at room temperature, it should be used within that 21-day period or discarded.
• -Avoid exposing the pen to excessive heat or direct sunlight.

During travel

• -Use an insulated medication bag or cooler pack if temperatures may exceed 30°C.
• -Do not place the medication directly against ice packs, as freezing can damage it.
• -Keep the medication in your carry-on luggage when flying.

⚠️ Disclaimer: This content is for informational purposes only and should not replace professional medical advice. Always consult a doctor before taking any new medication.